Fingerprint
Dive into the research topics of 'A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically